netFormulary Joint Medicines Formulary NHS
Airedale NHS Foundation Trust
Airedale, Wharfedale and Craven CCG
 Formulary Chapter 11: Eye - Full Chapter
Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand. 
11.06  Expand sub section  Treatment of glaucoma

Drugs that reduce intra-ocular pressure are used for managing glaucoma; they act by a variety of mechanisms. A topical beta-blocker or a prostaglandin analogue is commonly the drug of first choice. It may be necessary to combine these drugs or add others such as miotics, sympathomimetics and carbonic anhydrase inhibitors to control intra-ocular pressure.

11.06  Expand sub section  Beta-blockers
11.06  Expand sub section  Prostaglandin analogues
11.06  Expand sub section  Sympathomimetics
11.06  Expand sub section  Carbonic anhydrase inhibitors and systemic drugs to top
11.06  Expand sub section  Miotics
(Eye Drops)
View adult BNF View SPC online View childrens BNF  Track Changes
  • Pilocarpine 2% Eye Drops (with preservative)
  • Pilocarpine Nitrate 2% Eye Drops Minims (preservative free)
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Track Changes
Display tracking information
click to search
Link to adult BNF
click to search
Link to children's BNF
click to search
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHS England

Traffic Light Status Information

Status Description


Green - Drugs suitable for generalised use in accordance with position summary. Inform primary care of need to prescribe using a TTO chart if in patient or Treatment Advice Note (TAN) if Outpatient.   


Amber - these drugs require specialist initiation or recommendation  

Amber SCG

Amber Share Care - Drugs suitable for generalist use, in accordance with position summary, normally following specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  


Red - Drugs for specialist use only, in accordance with position summary. GPs should not be asked to prescribe these products.  


Red ULM - Unlicensed medicines for specialist use only, in accordance with position summary. GPs should not be asked to prescribe these products.  


Grey drugs - No formal commissioning position. Check appropriate CCG /NHSE commissioning list or contact CCG/NHSE Medicines Management team for advice. Fill in individual funding request for appropriate CCG/NHSE. This will need to be signed by the Chief Pharmacist and a copy of the relevant DTC submission attached.   


Black - Drugs not routinely commissioned so should not usually be prescribed